• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人特发性血小板减少性紫癜治疗失败的转归

Fate of therapy failures in adult idiopathic thrombocytopenic purpura.

作者信息

Picozzi V J, Roeske W R, Creger W P

出版信息

Am J Med. 1980 Nov;69(5):690-4. doi: 10.1016/0002-9343(80)90419-2.

DOI:10.1016/0002-9343(80)90419-2
PMID:7192052
Abstract

Of 38 adult patients with idiopathic thrombocytopenic purpura followed an average of more than 12 years, 15 suffered splenectomy failure or postsplenectomy recurrence of thrombocytopenia. Nine of the 15 also received immunosuppressive agents, and four of the nine failed such therapy. In eight of these 15 treatment failures normal or safe platelet counts were achieved in a subsequent three to 12 year period during which they received no therapy. The frequency of spontaneous recovery of satisfactory platelet levels in adults with idiopathic thrombocytopenic purpura in whom treatment failed may have negative implications for very vigorous or longstanding immunosuppressive therapeutic attempts in certain cases.

摘要

在38例平均随访超过12年的成人特发性血小板减少性紫癜患者中,15例出现脾切除失败或脾切除术后血小板减少复发。这15例患者中有9例还接受了免疫抑制剂治疗,其中4例治疗失败。在这15例治疗失败的患者中,有8例在随后3至12年未接受治疗的期间内血小板计数恢复正常或达到安全水平。对于某些治疗失败的成人特发性血小板减少性紫癜患者,满意的血小板水平自发恢复的频率可能对非常积极或长期的免疫抑制治疗尝试产生负面影响。

相似文献

1
Fate of therapy failures in adult idiopathic thrombocytopenic purpura.成人特发性血小板减少性紫癜治疗失败的转归
Am J Med. 1980 Nov;69(5):690-4. doi: 10.1016/0002-9343(80)90419-2.
2
[Therapeutic sequence in idiopathic thrombocytopenic purpura [].特发性血小板减少性紫癜的治疗顺序
Rev Invest Clin. 1982 Apr-Jun;34(2):113-9.
3
Idiopathic thrombocytopenic purpura during remission of thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜缓解期的特发性血小板减少性紫癜
South Med J. 1984 Dec;77(12):1599-601. doi: 10.1097/00007611-198412000-00034.
4
Splenectomy for idiopathic thrombocytopenic purpura.特发性血小板减少性紫癜的脾切除术
Surg Gynecol Obstet. 1987 Mar;164(3):225-9.
5
Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review.特发性血小板减少性紫癜的脾切除术:一项五年回顾性研究
Am Surg. 2000 Oct;66(10):952-4; discussion 955.
6
Splenectomy for primary and recurrent immune thrombocytopenic purpura (ITP). Current criteria for patient selection and results.原发性及复发性免疫性血小板减少性紫癜(ITP)的脾切除术。患者选择的当前标准及结果。
Ann Surg. 1987 Oct;206(4):529-41. doi: 10.1097/00000658-198710000-00014.
7
[Splenectomy in idiopathic thrombocytopenic purpura: short- and long-term results (author's transl)].
Wien Klin Wochenschr. 1978 Mar 31;90(7):233-6.
8
[Treatment of idiopathic thrombopenic purpura. Results obtained in a series of 219 cases].
Nouv Rev Fr Hematol (1978). 1982;24(2):59-68.
9
Results and prognostic factors of splenectomy in idiopathic thrombocytopenic purpura.特发性血小板减少性紫癜脾切除术的结果及预后因素
J Am Coll Surg. 1996 Dec;183(6):565-74.
10
Size of spleen rather than amount of platelet sequestration may determine long term responses to splenectomy in adult idiopathic thrombocytopenic purpura.在成人特发性血小板减少性紫癜中,脾脏大小而非血小板滞留量可能决定脾切除术后的长期反应。
J Clin Pathol. 1985 Oct;38(10):1172-4. doi: 10.1136/jcp.38.10.1172.

引用本文的文献

1
Long-term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program.在 3 期临床试验项目中,接受 fostamatinib 长期治疗的成人免疫性血小板减少症。
Am J Hematol. 2019 May;94(5):546-553. doi: 10.1002/ajh.25444. Epub 2019 Mar 13.
2
Rituximab in immune thrombocytopenia: transient responses, low rate of sustained remissions and poor response to further therapy in refractory patients.利妥昔单抗治疗免疫性血小板减少症:在难治性患者中,缓解持续时间短暂,缓解率低,对进一步治疗反应差。
Int J Hematol. 2010 Sep;92(2):283-8. doi: 10.1007/s12185-010-0635-4. Epub 2010 Jul 17.
3
Prediction of response to splenectomy in patients with idiopathic thrombocytopenic purpura.
特发性血小板减少性紫癜患者脾切除术反应的预测
World J Surg. 2008 Mar;32(3):488-93. doi: 10.1007/s00268-007-9399-2.
4
Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis.利妥昔单抗治疗慢性难治性免疫性血小板减少性紫癜:长期随访分析
Ann Hematol. 2007 Dec;86(12):871-7. doi: 10.1007/s00277-007-0317-3. Epub 2007 Sep 14.
5
Chronic idiopathic thrombocytopenic purpura.慢性特发性血小板减少性紫癜
Br Med J (Clin Res Ed). 1981 May 9;282(6275):1497-8. doi: 10.1136/bmj.282.6275.1497.
6
Treatment of refractory chronic idiopathic thrombocytopenic purpura with high dose intravenous immunoglobulin.
Blut. 1984 Jun;48(6):369-76. doi: 10.1007/BF00319965.
7
[Splenectomy in idiopathic thrombocytopenic purpura].[特发性血小板减少性紫癜的脾切除术]
Langenbecks Arch Chir. 1989;374(2):95-8. doi: 10.1007/BF01261617.